AliveCor
PrivateLast Round
Series F
Aug 16, 2022
Est. Valuation
$88.15M
Total Funding Raised
$159.38M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AliveCor operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Series F round in August 2022.
AliveCor is a healthcare technology company that develops FDA-cleared personal electrocardiogram (ECG) devices and AI-powered software for remote cardiac monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Telemedicine
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AliveCor Comparables
Compare AliveCor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coala-Life Group AB | 81% | |
| CardiacSense | 81% | |
| CardioComm Solutions, Inc. | 78% |
For institutional investors. Book with your work email.
AliveCor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Aug 16, 2022 | ||||
| Series E | Nov 16, 2020 | ||||
| VC Round | Oct 21, 2019 | ||||
| Debt | Jan 28, 2019 | ||||
| Series D | Mar 16, 2017 | ||||
Series C | Mar 31, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AliveCor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WP Global Partners | Series F, Series C, Series E |
| Oklahoma Life Science Fund | Series A, Series B |
| Khosla Ventures | Series F, Series D, Series B, Series E |
| Qualcomm Ventures | Series F, Series B, Series D, Series A, Series E |
| Burrill and Company | Series A, Series B |
| NGK Spark Plug | Series F |
| BOLD Capital Partners | Series D, Series F, Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2026
Added Vhss1, a startup in Government Contracting / Healthcare Services.
- Apr 7, 2026
Expanding AI cardiac diagnostics services and opening offices in Vietnam.
For institutional investors. Book with your work email.
AliveCor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AliveCor's valuation, stock price, and market status.
Is AliveCor a public or private company?
AliveCor is a private company.
What is the current stock price of AliveCor?
AliveCor is a private company, so its shares have no public market price. Caplight tracks AliveCor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AliveCor worth (valuation)?
AliveCor's valuation is estimated at $88.2M based on funding round data.
Can I buy AliveCor stock?
AliveCor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AliveCor's last funding round?
AliveCor's most recent funding round was Series F on August 16, 2022.
Who are the main investors in AliveCor?
Key investors in AliveCor include WP Global Partners, Khosla Ventures, Qualcomm Ventures, Burrill and Company, BOLD Capital Partners.
Will AliveCor IPO soon?
No public IPO plans have been announced for AliveCor.
How can I track AliveCor secondary market activity?
Caplight tracks bids, offers, and trades in AliveCor's shares on secondary markets.